Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11, and RUNX1-RUNX1T1

Detalles Bibliográficos
Autores principales: Lukes, Julius, Winkowska, Lucie, Zwyrtkova, Martina, Starkova, Julia, Sramkova, Lucie, Stary, Jan, Trka, Jan, Zuna, Jan, Zaliova, Marketa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665249/
https://www.ncbi.nlm.nih.gov/pubmed/33204999
http://dx.doi.org/10.1097/HS9.0000000000000489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665249/
https://www.ncbi.nlm.nih.gov/pubmed/33204999
http://dx.doi.org/10.1097/HS9.0000000000000489

Ejemplares similares